Page last updated: 2024-08-26

arsenic and Ameloblastoma

arsenic has been researched along with Ameloblastoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beachy, PA; Biscocho, J; Gong, X; Jones, CD; Koyota, S; Kwei, KA; McClary, AC; Myers, BR; Neahring, L; Ng, T; Odegaard, JI; Pelham, RJ; Pollack, JR; Qu, K; Rubin, BP; Sugiyama, T; Sweeney, RT; Troxell, ML; Varma, S; West, RB; Zehnder, JL	1

Other Studies

1 other study(ies) available for arsenic and Ameloblastoma

Article	Year
Identification of recurrent SMO and BRAF mutations in ameloblastomas. Nature genetics, 2014, Volume: 46, Issue:7 Topics: Ameloblastoma; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Cell Proliferation; High-Throughput Nucleotide Sequencing; Humans; Indoles; Jaw Neoplasms; Mutation; Oxides; Polymerase Chain Reaction; Proto-Oncogene Proteins B-raf; Receptors, G-Protein-Coupled; Smoothened Receptor; Sulfonamides; Tumor Cells, Cultured; Vemurafenib	2014

Article

Year

Identification of recurrent SMO and BRAF mutations in ameloblastomas.

Nature genetics, 2014, Volume: 46, Issue:7

Topics: Ameloblastoma; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Cell Proliferation; High-Throughput Nucleotide Sequencing; Humans; Indoles; Jaw Neoplasms; Mutation; Oxides; Polymerase Chain Reaction; Proto-Oncogene Proteins B-raf; Receptors, G-Protein-Coupled; Smoothened Receptor; Sulfonamides; Tumor Cells, Cultured; Vemurafenib

2014